Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : KCAP - Key Capital Corporation -- Ignore unavailable to you. Want to Upgrade?

To: Clive Roberts who wrote (214)	10/26/1998 7:49:00 PM
From: Bisset	Read Replies (2) \| Respond to of 459

While I am sure Rick Harmon is a most learned fellow, and may well be right about "immune adjuvants and biologic response modifiers" are frequently used catch phrases..., the doctor he is referring to has some fairly serious qualifications. From Dr. R. Urban's bio: Dr. Urban holds a Ph.D. in Immunology & Microbiology from the University of Colorado; an M.A. in Microbiology & Biochemistry from the University of Hartford; and a B.S. of Zoology & Chemistry from Arizona State. He achieved an appointment to the National Science Foundation in Microbiology at the University of California (Davis). Performed as a Principal Investigator, Tumor Immunotherapy at the University of Colorado and at the University of California Medical Center (San Diego). Assisted as Research Professor at Utah State, Department of Animal, Dairy and Veterinary Sciences - Animal Tumor Program. Research Fellow, University of Colorado Medical Center, Department of Surgery. Urban also has a Commendation from the US Navy Hospital Corps; a listing in the “American Men and Women of Science”; and is listed in the “Who's Who in the West”. If your Dr. Harmon can sport even half those credentials, I'm listening. And BTW, Crystal was initially funded by Key Capital as I understand it, but will be trading under its own symbol in the upcoming weeks. Oh yeah... it'll have its own medically-based web site. Bisset